Literature DB >> 11897764

Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2.

Masaru Miyataka1, Kathryn A Rich, Marylou Ingram, Tadahiko Yamamoto, Richard J Bing.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used as analgesics. They inhibit cyclooxygenases (COX), preventing the formation of prostaglandins, including prostacyclin and thromboxane. A serious side effect of COX-1 and COX-2 is renal damage. We report here that both a nonselective NSAID (aspirin, acetylsalicylic acid) and COX-2 selective NSAIDs (celecoxib and NS-398) diminished renal prostacyclin and thromboxane concentration in the renal medulla. NSAIDs failed to change COX-2 and iNOS (the inducible form of NO synthase) expression. A NO donor, B-NOD, preserved renal prostacyclin and thromboxane after administration of aspirin. PGI2 and COX-2 protein were mainly expressed in the renal medulla, whereas iNOS expression was greater in the cortex. B-NOD preserved renal prostacyclin levels after administration of NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897764     DOI: 10.1161/hy0302.105689

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  3 in total

1.  Anti-inflammatory activity of ethanolic extract from skipjack tuna (Katsuwonus pelamis) heart in LPS-induced RAW 264.7 cells and mouse ear edema model.

Authors:  Bo-Kyeong Kang; Min-Ji Kim; Koth-Bong-Woo-Ri Kim; Dong-Hyun Ahn
Journal:  Food Sci Biotechnol       Date:  2016-06-30       Impact factor: 2.391

Review 2.  Cyclooxygenase-2 inhibitors: is there an association with coronary or renal events?

Authors:  Richard J Bing
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

3.  Acute Kidney Injury Secondary to NSAID Diagnosed on 99mTc MDP Bone Scan.

Authors:  Ozhan Ozdoğan; Nazlı Pınar Karahan; Sülen Sarıoğlu; Hatice Durak
Journal:  Mol Imaging Radionucl Ther       Date:  2013-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.